Skip to main content

Table 1 Association between MAPKAPK5-AS1 expression and clinicopathologic features of hepatocellular carcinoma patients

From: Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression

Characteristics

n = 97

MAPKAPK5-AS1 levels

p-value

High (n = 49)

Low (n = 48)

Age (years)

   

0.774

  ≥ 60

64

33

31

  < 60

33

16

17

Gender

   

0.255

 Male

81

43

38

 Female

16

6

10

HBV infection

   

0.184

 Negative

19

7

12

 Positive

78

42

36

Liver cirrhosis

   

0.240

 Absent

29

12

17

 Present

68

37

31

AFP (ng/ml)

   

0.305

  ≤ 20

22

9

13

  > 20

75

40

35

Tumor size

   

0.006*

  ≤ 5 cm

41

14

27

  > 5 cm

56

35

21

Tumor multiplicity

   

0.001*

 Single

72

29

43

 Multiple

25

20

5

Vascular invasion

   

0.008*

 No

60

24

36

 Yes

37

25

12

TNM stage

   

0.001*

 I + II

78

33

45

 III + IV

19

16

3

  1. * indicates statistically significant